13-valent pneumococcal polysaccharide conjugate vaccine (Olymvax Biopharmaceuticals)

N/A

Report date: 2025/12/18 17:46:24

Base Information

Drug Name13-valent pneumococcal polysaccharide conjugate vaccine (Olymvax Biopharmaceuticals)
Drug Alias Namestreptococcus pneumoniae vaccine (polysaccharide conjugated 13-valent) (Olymvax Biopharmaceuticals)polysaccharide conjugated vaccine (Olymvax Biopharmaceuticals)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Oulin Biological Science & Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Oulin Biological Science & Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A